Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Puma Biotechnology (PBYI) Accumulated Depreciation & Amortization: 2017-2025

Historic Accumulated Depreciation & Amortization for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to $6.6 million.

  • Puma Biotechnology's Accumulated Depreciation & Amortization fell 17.38% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.5 million, marking a year-over-year decrease of 2.57%. This contributed to the annual value of $7.9 million for FY2024, which is 2.45% up from last year.
  • Puma Biotechnology's Accumulated Depreciation & Amortization amounted to $6.6 million in Q3 2025, which was down 18.41% from $8.1 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Accumulated Depreciation & Amortization registered a high of $8.1 million during Q2 2025, and its lowest value of $6.3 million during Q1 2021.
  • Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $7.8 million (2024), whereas its average is $7.7 million.
  • As far as peak fluctuations go, Puma Biotechnology's Accumulated Depreciation & Amortization increased by 11.54% in 2021, and later dropped by 17.38% in 2025.
  • Over the past 5 years, Puma Biotechnology's Accumulated Depreciation & Amortization (Quarterly) stood at $6.9 million in 2021, then climbed by 8.23% to $7.4 million in 2022, then increased by 3.42% to $7.7 million in 2023, then increased by 2.45% to $7.9 million in 2024, then decreased by 17.38% to $6.6 million in 2025.
  • Its last three reported values are $6.6 million in Q3 2025, $8.1 million for Q2 2025, and $8.0 million during Q1 2025.